- Home
- SIMO vs BLTE Comparison
SIMO vs BLTE Comparison
Compare SIMO & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIMO
- BLTE
- Stock Information
- Founded
- SIMO 1995
- BLTE 2018
- Country
- SIMO Hong Kong
- BLTE United States
- Employees
- SIMO N/A
- BLTE N/A
- Industry
- SIMO Semiconductors
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- SIMO Technology
- BLTE Health Care
- Exchange
- SIMO Nasdaq
- BLTE Nasdaq
- Market Cap
- SIMO 1.8B
- BLTE 1.7B
- IPO Year
- SIMO 2005
- BLTE 2022
- Fundamental
- Price
- SIMO $58.80
- BLTE $57.37
- Analyst Decision
- SIMO Strong Buy
- BLTE Strong Buy
- Analyst Count
- SIMO 8
- BLTE 4
- Target Price
- SIMO $80.63
- BLTE $96.33
- AVG Volume (30 Days)
- SIMO 499.3K
- BLTE 28.2K
- Earning Date
- SIMO 02-05-2025
- BLTE 03-10-2025
- Dividend Yield
- SIMO 3.40%
- BLTE N/A
- EPS Growth
- SIMO 69.06
- BLTE N/A
- EPS
- SIMO 2.68
- BLTE N/A
- Revenue
- SIMO $803,552,000.00
- BLTE N/A
- Revenue This Year
- SIMO $8.31
- BLTE N/A
- Revenue Next Year
- SIMO $12.67
- BLTE N/A
- P/E Ratio
- SIMO $21.94
- BLTE N/A
- Revenue Growth
- SIMO 25.72
- BLTE N/A
- 52 Week Low
- SIMO $48.81
- BLTE $31.01
- 52 Week High
- SIMO $85.87
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- SIMO 61.22
- BLTE 48.86
- Support Level
- SIMO $52.50
- BLTE $55.90
- Resistance Level
- SIMO $59.78
- BLTE $58.54
- Average True Range (ATR)
- SIMO 2.45
- BLTE 2.70
- MACD
- SIMO 0.67
- BLTE 0.24
- Stochastic Oscillator
- SIMO 81.47
- BLTE 52.14
About SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is active in the semiconductor industry and focuses on designing, developing, and marketing of controllers for managing NAND flash used in embedded storage applications, such as eMMC embedded memory. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.